Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans
- PMID: 3987789
- DOI: 10.1007/BF00635712
Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans
Abstract
Sparteine oxidation, which exhibits genetic polymorphism in various Caucasian populations, was studied in 154 unrelated Ghanaian subjects. Mean total urinary recovery of sparteine and 2- and 5-dehydrosparteines (56.6 +/- 16.6% of the dose) was not different from Caucasians. In contrast to Caucasians, amongst whom 6.3 to 9% of the population are poor metabolizers (PM), no PM subject was observed in the Ghanaian population sample. The data appear to indicate allelic differences between Caucasians and Ghanaians in the gene encoding the synthesis of the P-450 isozyme involved in polymorphic sparteine oxidation.
Similar articles
-
Evidence for polymorphic oxidation of sparteine in Japanese subjects.Br J Clin Pharmacol. 1987 Apr;23(4):482-5. doi: 10.1111/j.1365-2125.1987.tb03080.x. Br J Clin Pharmacol. 1987. PMID: 3580254 Free PMC article.
-
Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians.Clin Pharmacol Ther. 1985 May;37(5):512-21. doi: 10.1038/clpt.1985.81. Clin Pharmacol Ther. 1985. PMID: 3987174
-
Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians.Pharmacogenetics. 1998 Aug;8(4):325-33. doi: 10.1097/00008571-199808000-00006. Pharmacogenetics. 1998. PMID: 9731719
-
Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.Pharmacol Toxicol. 1990 Oct;67(4):273-83. doi: 10.1111/j.1600-0773.1990.tb00830.x. Pharmacol Toxicol. 1990. PMID: 2077517 Review.
-
The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms.Pharmacol Ther. 1990;46(2):297-308. doi: 10.1016/0163-7258(90)90096-k. Pharmacol Ther. 1990. PMID: 2181495 Review.
Cited by
-
Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasma.Eur J Clin Pharmacol. 1989;36(6):555-60. doi: 10.1007/BF00637735. Eur J Clin Pharmacol. 1989. PMID: 2590312
-
Genetically determined sparteine oxidation polymorphism in a Polish population.Eur J Clin Pharmacol. 1994;46(5):481-3. doi: 10.1007/BF00191917. Eur J Clin Pharmacol. 1994. PMID: 7957549 Clinical Trial.
-
No evidence for the presence of poor metabolizers of sparteine in an Amerindian group: the Cunas of Panama.Br J Clin Pharmacol. 1986 May;21(5):547-8. doi: 10.1111/j.1365-2125.1986.tb02841.x. Br J Clin Pharmacol. 1986. PMID: 3718812 Free PMC article. No abstract available.
-
Sparteine oxidation polymorphism: a family study.Br J Clin Pharmacol. 1986 Jun;21(6):661-7. doi: 10.1111/j.1365-2125.1986.tb05231.x. Br J Clin Pharmacol. 1986. PMID: 3741716 Free PMC article.
-
Evidence for polymorphic oxidation of sparteine in Japanese subjects.Br J Clin Pharmacol. 1987 Apr;23(4):482-5. doi: 10.1111/j.1365-2125.1987.tb03080.x. Br J Clin Pharmacol. 1987. PMID: 3580254 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources